KIR2DS1-Positive NK Cells Mediate Alloresponse against the C2 HLA-KIR Ligand Group In Vitro1
暂无分享,去创建一个
J. Chewning | K. Hsu | A. Selvakumar | C. Gudme | B. DuPont
[1] P. Wernet,et al. Relevance of C1 and C2 Epitopes for Hemopoietic Stem Cell Transplantation: Role for Sequential Acquisition of HLA-C-Specific Inhibitory Killer Ig-Like Receptor1 , 2007, The Journal of Immunology.
[2] D. Nixon,et al. Cutting Edge: KIR3DS1, a Gene Implicated in Resistance to Progression to AIDS, Encodes a DAP12-Associated Receptor Expressed on NK Cells That Triggers NK Cell Activation1 , 2007, The Journal of Immunology.
[3] P. Parham,et al. Functional Polymorphism of the KIR3DL1/S1 Receptor on Human NK Cells1 , 2007, The Journal of Immunology.
[4] D. Middleton,et al. Human NK cell education by inhibitory receptors for MHC class I. , 2006, Immunity.
[5] R. Vance,et al. Self-tolerance of natural killer cells , 2006, Nature Reviews Immunology.
[6] P. Parham,et al. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function , 2006, The Journal of experimental medicine.
[7] Eric O Long,et al. Activation of NK Cells by an Endocytosed Receptor for Soluble HLA-G , 2005, PLoS biology.
[8] J. Trapani,et al. Molecular mapping of a new public HLA class I epitope shared by all HLA-B and HLA-C antigens and defined by a monoclonal antibody , 2006, Immunogenetics.
[9] D. F. Barber,et al. Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells , 2005, The Journal of experimental medicine.
[10] Eric Vivier,et al. Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[11] L. Lybarger,et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules , 2005, Nature.
[12] R. Schots,et al. A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation , 2005, Leukemia.
[13] M. Horowitz,et al. Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. , 2005, Blood.
[14] R. Vance,et al. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. , 2005, Blood.
[15] F. Behm,et al. Comparison of Killer Ig-Like Receptor Genotyping and Phenotyping for Selection of Allogeneic Blood Stem Cell Donors1 , 2005, The Journal of Immunology.
[16] L. Lanier,et al. Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell–mediated innate resistance to cytomegalovirus infection , 2005, Nature Genetics.
[17] P. Parham,et al. Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues , 2005, The Journal of experimental medicine.
[18] Akiko Kikuchi-Maki,et al. Cutting Edge: KIR2DL4 Transduces Signals into Human NK Cells through Association with the Fc Receptor γ Protein1 , 2005, The Journal of Immunology.
[19] Lewis L Lanier,et al. NK cell recognition. , 2005, Annual review of immunology.
[20] M. Carrington,et al. Cutting Edge: Heterozygote Advantage in Autoimmune Disease: Hierarchy of Protection/Susceptibility Conferred by HLA and Killer Ig-Like Receptor Combinations in Psoriatic Arthritis1 , 2004, The Journal of Immunology.
[21] Salim I. Khakoo,et al. HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection , 2004, Science.
[22] J. P. McCoy,et al. Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells. , 2004, Blood.
[23] T. Sasazuki,et al. Genetic polymorphisms of killer cell immunoglobulin-like receptors are associated with susceptibility to psoriasis vulgaris. , 2004, The Journal of investigative dermatology.
[24] C. Craddock,et al. The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia. , 2004, Blood.
[25] R. Handgretinger,et al. Determinants of Antileukemia Effects of Allogeneic NK Cells 1 , 2004, The Journal of Immunology.
[26] Franco Locatelli,et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. , 2003, Blood.
[27] D. Fremont,et al. Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors , 2003, Nature Immunology.
[28] Kouhei Tsumoto,et al. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[29] Mary Carrington,et al. The KIR Gene Cluster , 2003 .
[30] K. Hsu,et al. The killer cell immunoglobulin‐like receptor (KIR) genomic region: gene‐order, haplotypes and allelic polymorphism , 2002, Immunological reviews.
[31] Eric Mickelson,et al. Killer Ig-Like Receptor Haplotype Analysis by Gene Content: Evidence for Genomic Diversity with a Minimum of Six Basic Framework Haplotypes, Each with Multiple Subsets1 , 2002, The Journal of Immunology.
[32] Keith Hoots,et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS , 2002, Nature Genetics.
[33] N. Shastri,et al. A Ligand for the Murine NK Activation Receptor Ly-49D: Activation of Tolerized NK Cells from β2-Microglobulin- Deficient Mice1 , 2002, The Journal of Immunology.
[34] L. Lanier,et al. Direct Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell Receptors , 2002, Science.
[35] Katia Perruccio,et al. Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants , 2002, Science.
[36] J. Zimmer,et al. Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells. , 2002, Blood.
[37] Peter Parham,et al. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. , 2002, Annual review of immunology.
[38] Steffen Jung,et al. Spatial Organization of Signal Transduction Molecules in the NK Cell Immune Synapses During MHC Class I-Regulated Noncytolytic and Cytolytic Interactions , 2001, The Journal of Immunology.
[39] J. Miller,et al. Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2. , 2001, Blood.
[40] O. Mandelboim,et al. Recognition of HLA-Cw4 but Not HLA-Cw6 by the NK Cell Receptor Killer Cell Ig-Like Receptor Two-Domain Short Tail Number 41 , 2001, The Journal of Immunology.
[41] Daniel J. Schaid,et al. Major Histocompatibility Complex Class I–Recognizing Receptors Are Disease Risk Genes in Rheumatoid Arthritis , 2001, The Journal of experimental medicine.
[42] J. Ortaldo,et al. Tolerance and alloreactivity of the Ly49D subset of murine NK cells. , 1999, Journal of immunology.
[43] A. Tosti,et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. , 1999, Blood.
[44] J. Ortaldo,et al. Positive recognition of MHC class I molecules by the Ly49D receptor of murine NK cells. , 1999, Journal of immunology.
[45] W. Seaman,et al. Mouse Ly-49D Recognizes H-2Dd and Activates Natural Killer Cell Cytotoxicity , 1999, The Journal of experimental medicine.
[46] J. Strominger,et al. Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[47] Eric O Long,et al. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. , 1998, Journal of immunology.
[48] M. Colonna,et al. Signaling through human killer cell activating receptors triggers tyrosine phosphorylation of an associated protein complex , 1998, European journal of immunology.
[49] J. Zimmer,et al. Activity and Phenotype of Natural Killer Cells in Peptide Transporter (TAP)-deficient Patients (Type I Bare Lymphocyte Syndrome) , 1998, The Journal of experimental medicine.
[50] P Parham,et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. , 1997, Immunity.
[51] R. Biassoni,et al. Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA‐Cw4 molecules , 1997, European journal of immunology.
[52] P Parham,et al. Human diversity in killer cell inhibitory receptor genes. , 1997, Immunity.
[53] Nallasivam Palanisamy,et al. Genomic organization and allelic polymorphism of the human killer cell inhibitory receptor gene KIR 103 , 1997 .
[54] É. Vivier,et al. Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. , 1997, Journal of immunology.
[55] R S Chaganti,et al. Genomic organization and allelic polymorphism of the human killer cell inhibitory receptor gene KIR103. , 1997, Tissue antigens.
[56] S. Anderson,et al. The Ly-49D Receptor Activates Murine Natural Killer Cells , 1996, The Journal of experimental medicine.
[57] R. Biassoni,et al. The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions , 1996, The Journal of experimental medicine.
[58] L. Moretta,et al. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells , 1995, The Journal of experimental medicine.
[59] H. Ljunggren,et al. In search of the 'missing self': MHC molecules and NK cell recognition. , 1990, Immunology today.